Five Star Equities Provides Stock Research on Rare Element Resources and Quest Rare Minerals
Continue ReadingTag: analyst-reports
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Progenics Pharmaceuticals and Vical
Continue ReadingBiotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Incyte and Oncolytics Biotech
Continue ReadingNatural Gas Stocks in a Slump as Prices for the Commodity Fall Sharply on Lower Heating Demand
The Paragon Report Provides Stock Research on Exxon Mobil and Ultra Petroleum
Continue ReadingOil and Gas Continues to Battle Slowing Demand — U.S. Oil Demand Falls to a 17-Year Low in October
The Paragon Report Provides Stock Research on Ivanhoe Energy and Talisman Energy
Continue ReadingSpecial Dividend Payments Surge in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase
Five Star Equities Provides Stock Research on CVS Caremark and Walgreen
Continue ReadingNumber of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms
Five Star Equities Provides Stock Research on Coca-Cola and Procter & Gamble
Continue ReadingIncreased Production and Dropping Demand Continue to Pressure Oil Prices
The Paragon Report Provides Stock Research on Hyperdynamics and Pengrowth Energy
Continue ReadingAmount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011
Five Star Equities Provides Stock Research on ConAgra Foods and Mondelez International
Continue ReadingHigher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Arena Pharmaceuticals and VIVUS
Continue Reading